Evidence map›Paper›PMID 33905472›Full record

ArticleThe review of diabetic studies : RDS2020

Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes.

Mahtab Irani, Mohammad Sarafraz Yazdi, Meisam Irani, Sina Naghibi Sistani, Sahar Ghareh

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The review of diabetic studies : RDS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mahtab IraniFaculty of Medicine, Islamic Azad University, Mashhad branch, Mashhad, Iran.
Mohammad Sarafraz YazdiDepartment of Internal Medicine, Mashhad Medical Sciences Branch, Islamic Azad University, Mashhad, Iran.
Meisam IraniFaculty of Medicine, Shahrood Medical Sciences Branch, Islamic Azad University, Shahrood, Iran.
Sina Naghibi SistaniDepartment of Psychology, Ferdowsi University of Mashhad, Faculty of Education Sciences and Psychology, Mashhad, Iran.
Sahar GharehDepartment of Endocrinology, Mashhad Medical Sciences Branch, Islamic Azad University, Mashhad, Iran.
Islamic Azad University, Mashhad · IRIslamic Azad University, Shahrood · IRFerdowsi University of Mashhad · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes is a global health problem that has affected more than 400 million people worldwide. Adherence to treatment is considered to be one of the most important and deterministic factors in the treatment of diabetes. This study investigates medication adherence and factors affecting it in patients with type 2 diabetes.

methodsThis cross-sectional study investigated 136 patients with type 2 diabetes in 2018-2019. Data collection was done using a checklist that included information on personal characteristics, medication, and healthcare. The collected data were analyzed by statistical tests in SPSS 25 software.

results79.4% of the patients adhered to prescribed medication. Medication adherence had no significant relationship with taking other drugs, fasting blood sugar (FBS), and the daily number of hypoglycemic tablets (p ˃ 0.05). However, adherence to medication was significantly associated with age, gender, income, hemoglobin A1c, medication period, and hypoglycemia (p ˂ 0.05).

conclusionsHigher levels of adherence were observed among females aged below 60 years, with higher income, a hemoglobin A1c level below 7%, a medication period of less than 10 years, and among patients without hypoglycemia. Regarding drug type, adherence levels were lower in people taking glibenclamide.

Indexed as

Diabetes Mellitus, Type 2Pharmaceutical PreparationsCross-Sectional StudiesFemaleGlycated HemoglobinHumansHypoglycemic AgentsPrescriptionsGlycated HemoglobinHypoglycemic AgentsPharmaceutical Preparations

Identifiers

PMID33905472
PMCPMC9380091
OpenAlexW3159127980

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.